MSP-1001

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMSP-1001
Drug Alias Namepsilocybin-inspired compound (Mindset Pharma)MSP-1001
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor modulators
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsMental DisordersNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMindset Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMindset Pharma Inc
Active IndicationsN/A
Inactive IndicationsMental DisordersNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A